Moreover, dopamine signaling is a critically important process in the brain, and dopamine receptors (DARs) are closely related to neurodegenerative diseases such as AD and have become an important target for the prevention and treatment of AD (Reeves et al., 2017; Pan et al., 2019). This evidence concerns the gene DARS1 and neurodegenerative disease.